Comparative Study between Wild and Commercial Egyptian Lactobacillus reuteri-Antagonizing Effects in Cryptosporidiosis Models

Bibliographic Information
Authors: Fahmy A.; AbuelenAin G.; Abdou A.; Elhakeem M.
Journal: Advances in Animal and Veterinary Sciences
Publisher: Nexus Academic Publishers
Publication Date: April 2021
Volume / Issue: Volume 9 / Issue 6
Pages: 802–810
ISSN: 23093331
DOI: 10.17582/journal.aavs/2021/9.6.802.810
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Gold Open Access
Authors and Affiliations
Fahmy A., Department of Immunology and Drug Evaluation, TBRI, Giza, Egypt, FCHS, IAT, P.O. Box 111534, United Arab Emirates; AbuelenAin G., Department of Immunology and Drug Evaluation, TBRI, Giza, Egypt, FCHS, IAT, P.O. Box 111534, United Arab Emirates; Abdou A., Department of Microbiology and Immunology, NRC, Giza, Egypt; Elhakeem M., Water Resources and Environmental Engineering, ADU, Abu Dhabi, United Arab Emirates, University of Tennessee, Knoxville, TN, United States
Abstract
To investigate the prophylactic and therapeutic potentiality of Egyptian probiotic Lactobacillus reuteri in the cryptosporidiosis model (hereafter home-isolated probiotic). As per the health conditions of the experimental mice, they were deployed into two main batches: immunocompetent and immunocompromised. Each batch comprised three protocols as per the types of the treatment (home-isolated-, commercial probiotics, and Nitazoxanide). A dose of 108 colony-forming unit (cfu) Lactobacillus reuteri isolated from the domestic camels and the commercial strain were administered orally on daily basis for 10 days. Then, mice were infected with approximately 1 x 104 inoculums of Cryptosporidium cysts with continuous administration of probiotics till the end of the experiment (day 20). The regression decay models were utilized to predict the recovery rate of the experimental mice at days different from the tested ones using the data collected from the Nitazoxanide-different time-scheduled protocol. The response to the treatment by probiotics in the immunocompromised mice is less than that of the immunocompetent mice. Positive outcome results are in favor of the home-isolated probiotic treatment. On the contrary, Nitazoxanide is the treatment with the highest number of cysts recovered from the experimental mice. In a nutshell, the results demonstrate that the home-isolated probiotic is efficient in decolonizing the Cryptosporidium spp. cysts and ameliorating the pathogenicity of the disease. Besides, this research study is shedding the light on the importance of isolating and utilizing a country/region-based Lactobacillus reuteri probiotic for high-efficiency treatment of cryptosporidiosis in immunodeficient cases. © 2021 Abuelenain et al. All Rights Reserved.
Keywords
Cryptosporidiosis; Drug discovery; Nitazoxanide; Probiotic
Citation Information
Scopus Citations: 5
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
